EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) today announced that Michael Kauffman, M.D., Ph.D., has resigned from his position as CEO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE